Rebecca Croasdale
Roche Pharma AG (Germany)(DE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, HER2/EGFR in Cancer Research, Protein Structure and Dynamics, Galectins and Cancer Biology
Most-Cited Works
- → Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies(2011)462 cited
- → Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies(2012)199 cited
- → Bispecific digoxigenin-binding antibodies for targeted payload delivery(2011)70 cited
- → Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains(2011)62 cited
- → A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties(2014)58 cited
- → Development of tetravalent IgG1 dual targeting IGF-1R–EGFR antibodies with potent tumor inhibition(2012)46 cited
- → Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies(2012)45 cited
- → An Undecided Coiled Coil(2011)38 cited
- → Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing(2012)36 cited
- → XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer(2016)31 cited